A Phase-II, Randomized, Placebo-Controlled, Parallel-Group Clinical Trial to Study the Efficacy and Safety of MK-1029 in Adult Subjects With Persistent Asthma That is Uncontrolled While Receiving Montelukast.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 08 Aug 2017
At a glance
- Drugs MK 1029 (Primary) ; Montelukast
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme
- 15 Jun 2017 Planned End Date changed from 11 Dec 2017 to 7 Sep 2017.
- 15 Jun 2017 Planned primary completion date changed from 11 Dec 2017 to 7 Sep 2017.
- 15 Jun 2017 Status changed from recruiting to active, no longer recruiting.